RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...

Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins CNBC's 'Squawk Box' to discuss market outlooks, ...

RBC Capital Markets has upgraded the Utilities sector to Overweight, naming it the top defensive sector, while downgrading ...

RBC Capital Markets upgrades Bank of Montreal and Canadian Imperial Bank of Commerce to Outperform, citing positive outlook ...

RBC Capital analyst Mike Dahl raised the firm’s price target on Vulcan Materials (VMC) to $269 from $259 and keeps a Sector Perform rating on ...

Scotiabank analyst Mario Saric thinks the worst may be over for domestic office REITs, ...

In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

RBC Capital Markets周一发布了其2025年的首选股名单，其中包括一家能源巨头和一家重要的金融公司。

Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...

该公司对Ultragenyx的成骨不全症 (OI)药物持乐观态度，预计第三期临床试验数据即将发布。尽管RBC Capital承认试验存在风险，如第二期试验样本量小、第三期患者病情更重以及安慰剂反应建模困难等，但仍对该药物的潜在成功持乐观态度。